Filing Details
- Accession Number:
- 0001209191-16-101528
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-02-23 17:45:34
- Reporting Period:
- 2016-02-19
- Filing Date:
- 2016-02-23
- Accepted Time:
- 2016-02-23 17:45:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 353569 | Quidel Corp | QDEL | In Vitro & In Vivo Diagnostic Substances (2835) | 942573850 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1406652 | C Douglas Bryant | 12544 High Bluff Drive, Suite 200 San Diego CA 92130 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-02-19 | 3,700 | $13.91 | 254,293 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The weighted average purchase price for these transactions was $13.91 per share, with a range of $13.87 to $13.98 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price.
- The amount of securities beneficially owned following this transaction include an additional 1,189 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan.
Billionaire Hedge Funds
